Evidence for Health Improvement in People With Diabetes Using One Touch & Partner Solutions
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 800 participants.
Also called NCT05354297
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 800 participants
- Sponsor
- LifeScan
- Registry
-
NCT05354297
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Unknown status
Technical summary
Registry record NCT05354297. Non-randomized; no masking; primary purpose treatment. Start 2022-07-26 (anticipated); primary completion 2023-04-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Evidence for Health Improvement in People With Diabetes Using One Touch & Partner Solutions
- Acronym
- ECLIPSE
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Device)
- Cecelia Health plus OneTouch Verio Reflect® BGM and OneTouch Reveal® mobile app
- Intervention (Device)
- Fitbit plus OneTouch Verio Reflect® BGM and OneTouch Reveal® mobile app
- Intervention (Device)
- Noom plus OneTouch Verio Reflect® BGM and OneTouch Reveal® mobile app
- Intervention (Device)
- Welldoc plus OneTouch Verio Reflect® BGM and Welldoc app
- Lead sponsor
- LifeScan
- Collaborator
- Evidation Health
Record details
- Record id
cardio:ct-nct05354297- Content hash
c465a81c7da191c77bf6a049be4f880d4457458905694044bc8fe14fb43a7c51